Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. - Abstract - Europe PMC

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Cancers, Free Full-Text

Full article: Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer

Molecular landscape of high-risk early breast cancer. Tumor samples are

RNA-Seq assay identifies target genes of MLL3 and MLL4 in metabolism.

Frontiers Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

PDF) Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer

Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets

Heterogeneity and transcriptional drivers of triple-negative breast cancer - ScienceDirect

Heterogeneity and transcriptional drivers of triple-negative breast cancer - ScienceDirect